Suppr超能文献

特发性扩张型心肌病的遗传学

Genetics of idiopathic dilated cardiomyopathy.

作者信息

Arbustini E, Morbini P, Pilotto A, Gavazzi A, Tavazzi L

机构信息

Pathology Department, IRCCS Policlinico S. Matteo, Pavia, Italy.

出版信息

Herz. 2000 May;25(3):156-60. doi: 10.1007/s000590050001.

Abstract

Familial dilated cardiomyopathy (DCM) should be an "evidence-based" diagnosis derived from clinical and echocardiographic screening of informed and consenting relatives of index patients, and on the examination of clinical reports for deceased relatives. Most familial dilated cardiomyopathy pedigrees show an autosomal pattern of inheritance. Very few of them are X-linked and matrilinear. Autosomal recessive inheritance is difficult to be assessed in an evidence-based setting. By linkage analysis, several loci, but no disease gene, have been identified. At present, few cases of familial dilated cardiomyopathy can benefit of a molecular diagnosis. The diagnosis of dystrophin defect-related dilated cardiomyopathy is important for patients and families, especially for carrier detection. These patients present X-linked inheritance, dominant cardiac involvement and raised levels of serum creatine phosphokinase. Defects of the glycoprotein complex associated to dystrophin (DAG) are rare skeletal muscle diseases with possible cardiac involvement. Mitochondrial diseases, both pure cardiomyopathies and multiorgan syndromes involving the heart, are associated to defects of mitochondrial DNA genes or of nuclear genes coding for mitochondrial proteins. Barth's syndrome develops in male children with granulocytopenia, dilated cardiomyopathy, and methylglutaconic aciduria. Cardiomyopathies with atrioventricular block are observed in hemochromatosis, Emery-Dreifuss syndrome, desmin storage disease, and in isolated familial dilated cardiomyopathy. Actin defects were recently identified in 2 unrelated patients with familial dilated cardiomyopathy. Desmin defects were also recently identified in 1 familial dilated cardiomyopathy. The overall knowledge, although in progression, is still limited. Clinical family screening identifies familial forms, preclinical cases, and inheritance pattern. By candidate gene screening, the molecular diagnosis can be provided for dystrophin, DAG, mitochondrial DNA, actin and desmin gene defects.

摘要

家族性扩张型心肌病(DCM)应是一种“基于证据”的诊断,它源自对先证者知情且同意的亲属进行临床和超声心动图筛查,并检查已故亲属的临床报告。大多数家族性扩张型心肌病家系呈现常染色体遗传模式。其中X连锁和母系遗传的情况非常少见。常染色体隐性遗传在基于证据的情况下难以评估。通过连锁分析,已确定了几个位点,但尚未发现致病基因。目前,很少有家族性扩张型心肌病病例能从分子诊断中受益。肌营养不良蛋白缺陷相关的扩张型心肌病的诊断对患者及其家庭很重要,尤其是对于携带者检测。这些患者表现为X连锁遗传、主要累及心脏且血清肌酸磷酸激酶水平升高。与肌营养不良蛋白相关的糖蛋白复合物(DAG)缺陷是罕见的骨骼肌疾病,可能累及心脏。线粒体疾病,包括单纯性心肌病和累及心脏的多器官综合征,与线粒体DNA基因或编码线粒体蛋白的核基因缺陷有关。巴特综合征发生于患有粒细胞减少症、扩张型心肌病和甲基戊二酸尿症的男性儿童。在血色素沉着症、埃默里 - 德赖富斯综合征、结蛋白贮积病以及散发性家族性扩张型心肌病中可观察到伴有房室传导阻滞的心肌病。最近在2例不相关的家族性扩张型心肌病患者中发现了肌动蛋白缺陷。最近在1例家族性扩张型心肌病中也发现了结蛋白缺陷。尽管总体知识仍在不断发展,但仍然有限。临床家系筛查可识别家族性类型、临床前病例和遗传模式。通过候选基因筛查,可以对肌营养不良蛋白、DAG、线粒体DNA、肌动蛋白和结蛋白基因缺陷进行分子诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验